Welcome to LIT.org! This website LIT.org is For Sale!. You can make an offer on the Contact page.
Lymphocyte Immunization Therapy (LIT) in Fertility Treatment
Companies making medications for therapies related to LIT (Lymphocyte Immunization Therapy) are challenging to identify directly due to the therapy’s unapproved status in many regions, including the United States. However, companies working in broader immunotherapy areas may be involved in related research or development, or in providing components used in such therapies.
Here are some companies and organizations that have been mentioned in contexts related to immunotherapy and LIT, keeping in mind the regulatory status of LIT itself:
Pharmaceutical and Biotech Companies with Immunotherapy Divisions/Interests:
Pfizer: Has developed LITFULO (ritlecitinib), an FDA-approved kinase inhibitor for alopecia areata.
Novartis: Has developed CAR-T cell therapies like Kymriah and Tecartus for various types of cancer.
Merck & Co. Inc. (US): Known for its pipeline of immunotherapeutic drugs, especially in oncology.
Johnson & Johnson Services, Inc. (US): Offers a wide range of immunotherapy drugs and has many FDA/EC-approved immunotherapy drugs.
F. Hoffmann-La Roche Ltd (Switzerland): Provides an extensive range of Immunotherapy Drugs for end users like hospitals and specialty care centers.
Amgen Inc. (NASDAQ: AMGN): Focused on the formulation of bispecific T-cell engager (BiTE) antibodies for cancer.
Bristol-Myers Squibb Company (NYSE: BMY): Exploring various types of immunotherapies, including cell and gene therapy.
Other companies: Adaptimmune, Celldex Therapeutics, Dragonfly Therapeutics (United States), AbbVie, Elicera Therapeutics, Fate Therapeutics, GammaDelta Therapeutics, Senti Biosciences, Alaunos Therapeutics, Aurion Biotech, Bluebird Bio, Celgene Corporation, ElevateBio, Pionyr Immunotherapeutics, CARsgen Therapeutics, Affimed Therapeutics, NodThera, Orum Therapeutics, Arcellx, Turnstone Biologics, Inotrem, Hummingbird Bioscience, Iovance Biotherapeutics.
Companies Focused on Fertility Treatment Innovation:
Gameto: This company is developing treatment solutions for women’s health, including infertility, with their lead program Fertilo, which aims to make IVF and egg freezing shorter, safer, and more accessible.
Celmatix Inc.: Developing novel drug development programs focused on women’s health indications like PCOS and fertility treatments.
Companies Involved in Components for Cell and Gene Therapy:
Miltenyi Biotec: In partnership with the Leibniz Institute for Immunotherapy (LIT), they are developing a cGMP-compliant, semi-automated manufacturing platform for generating CD22/CD19-bispecific CD8+ Tscm cells.
Specialized Clinics and Medical Centers (often involved in LIT administration or research):
NewLIFE Fertility/New Leaders In Fertility & Endocrinology LLC: A fertility clinic in Panama City, FL.
Optimal Bio: Specializes in Bioidentical Hormone Replacement Therapy (BHRT) in Inlet Beach, FL.
Institute of Endocrinology, Diabetes, Health & Hormones: Located in Destin, FL.
Advanced Reproductive Specialists of Panama City: A fertility clinic.
QIR Fertility: Lists Lymphocyte Immunization Therapy (LIT) among their services.
Alan E. Beer Medical Center for Reproductive Immunology.
Important Considerations
Regulatory Status of LIT: Lymphocyte Immunization Therapy (LIT) is currently considered experimental in the United States and is not approved by the FDA for routine clinical use. Its use is restricted to study purposes. Availability and use may vary depending on the country or region.
Controversy and Research: There is ongoing debate and research surrounding the efficacy of LIT. Some studies have shown promising results in improving live birth rates, while others have raised questions about its effectiveness due to limitations in study design or inconsistent findings.
It is crucial for individuals seeking LIT or related treatments to thoroughly research the therapy, understand its limitations, and consult with qualified medical professionals for accurate and up-to-date information regarding its availability, safety, and effectiveness in their specific circumstances.